Cleveland Clinic Intensive Review of Endocrinology & Metabolism 2026

Cleveland Clinic’s 2026 endocrinology review combines specialist lectures, clinical cases and board simulations across endocrine and metabolic medicine. It covers diabetes treatment and technology, thyroid and adrenal disorders, pituitary disease, obesity, reproductive endocrinology, bone health and lipid management. Endocrine surgery and pediatric case reviews add practical context for endocrinologists, internal medicine physicians and trainees preparing for examinations or refreshing their knowledge.

The agenda below is from the September 25–27, 2026 conference in Cleveland and is not a recording inventory. This meeting is distinct from the similarly named Oakstone edition released in December 2025. Provider registration and livestream access are not included with the store’s study materials.

Course Directors

Robert Zimmerman, MD

Director, Diabetes Center, Cleveland Clinic.

M. Cecilia Lansang, MD, MPH

Endocrinology, Cleveland Clinic.

The conference faculty includes Cleveland Clinic specialists and invited educators with expertise in diabetes, thyroid disease, adrenal medicine, reproductive endocrinology, metabolic bone disorders, lipidology, and endocrine surgery.

Official Learning Objectives

Upon completion of the original educational activity, participants should be better able to:

1. Describe diabetes complications and examine the clinical impact of new insulin and incretin-based treatments.
2. Compare management strategies for endocrine hypertension, adrenal insufficiency, congenital adrenal hyperplasia, hypoglycemia, and obesity.
3. Recognize endocrine considerations relevant to the care of transgender patients.
4. Explain different clinical approaches to male and female hypogonadism.
5. Review endocrine surgery cases and pediatric endocrine disorders.
6. Summarize practical clinical issues involving thyroid nodules, thyroid cancer, hyperthyroidism, hypothyroidism, and menopause.
7. Review diagnostic and treatment approaches to thyroid, pituitary, and adrenal gland disorders.
8. Evaluate metabolic bone disease, osteoporosis, vitamin D deficiency, hypercalcemia, and hypocalcemia.

Topics